SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $145,323,000 | +2952.4% | 840,943 | +1930.3% | 0.31% | +2709.1% |
| Q4 2014 | $4,761,000 | -31.6% | 41,419 | -7.0% | 0.01% | -42.1% |
| Q3 2014 | $6,957,000 | -78.1% | 44,525 | -82.7% | 0.02% | -74.3% |
| Q2 2014 | $31,802,000 | +240.5% | 257,819 | +186.0% | 0.07% | +236.4% |
| Q1 2014 | $9,339,000 | -61.3% | 90,134 | -66.4% | 0.02% | -62.1% |
| Q4 2013 | $24,151,000 | +37.8% | 268,519 | +2.4% | 0.06% | +34.9% |
| Q3 2013 | $17,529,000 | -21.7% | 262,100 | -22.5% | 0.04% | -27.1% |
| Q2 2013 | $22,380,000 | – | 338,319 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 173,845 | $7,037,000 | 0.28% |
| AMUNDI ASSET MANAGEMENT US, INC. | 537,900 | $21,774,000 | 0.09% |
| NOMURA HOLDINGS INC | 127,903 | $5,175,000 | 0.06% |
| GOLDMAN SACHS GROUP INC | 386,458 | $15,641,000 | 0.01% |
| AQR Capital Management | 26,000 | $1,052,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 100,000 | $4,047,000 | 0.00% |
| RATIONAL ADVISORS LLC | 288 | $12,000 | 0.00% |
| HSBC HOLDINGS PLC | 5,448 | $220,000 | 0.00% |